Avoid other GLP-1 or GIP agonists like semaglutide or tirzepatide alongside Retatrutide due to overlapping mechanisms and compounded side effects
In more complex or persistent cases, I may recommend targeted testing, including advanced skin or gut microbiome testing, to better understand: Bacterial imbalances Yeast overgrowth Staphylococcus dominance Gut patterns that may be contributing to skin inflammation Toxic overload Hormonal imbalances And more
Professional websites, clear contact information, and transparent policies suggest legitimate operations
The main stack-specific consideration is overlap of angiogenic signaling from BPC-157 and TB-500, which is why people with active cancer or vascular disorders are advised to avoid these compounds
Research priorities in pernicious anaemia: James Lind Alliance Priority Setting Partnership
Metabolism naturally slows during menopause, and the digestive system becomes less efficient at processing food